158 related articles for article (PubMed ID: 38061402)
1. Pre-extensively drug-resistant and extensively drug-resistant tuberculosis in Latin America and the Caribbean: A systematic review and meta-analysis.
Alarcon-Braga EA; Salazar-Valdivia FE; Estrada-Grossmann JM; Mendez-Guerra C; Pacheco-Barrios N; Al-Kassab-Córdova A
Am J Infect Control; 2024 Mar; 52(3):349-357. PubMed ID: 38061402
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis.
Diriba G; Alemu A; Yenew B; Tola HH; Gamtesa DF; Mollalign H; Eshetu K; Moga S; Abdella S; Tollera G; Kebede A; Dangisso MH
Int J Infect Dis; 2023 Jul; 132():50-63. PubMed ID: 37072053
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic accuracy of the GenoType(®) MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs.
Theron G; Peter J; Richardson M; Barnard M; Donegan S; Warren R; Steingart KR; Dheda K
Cochrane Database Syst Rev; 2014 Oct; (10):CD010705. PubMed ID: 25353401
[TBL] [Abstract][Full Text] [Related]
4. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
Dreyer V; Mandal A; Dev P; Merker M; Barilar I; Utpatel C; Nilgiriwala K; Rodrigues C; Crook DW; ; Rasigade JP; Wirth T; Mistry N; Niemann S
Genome Med; 2022 Aug; 14(1):95. PubMed ID: 35989319
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of drug-resistant pulmonary tuberculosis in India: systematic review and meta-analysis.
Goyal V; Kadam V; Narang P; Singh V
BMC Public Health; 2017 Oct; 17(1):817. PubMed ID: 29041901
[TBL] [Abstract][Full Text] [Related]
6. A five-year review of prevalence and treatment outcomes of pre-extensively drug-resistant plus additional drug-resistant tuberculosis in the Henan Provincial Tuberculosis Clinical Medicine Research Centre.
Li Z; Liu F; Chen H; Han Y; You Y; Xie Y; Zhao Y; Tan J; Guo X; Cheng Y; Wang Y; Li J; Cheng M; Xia S; Niu X; Wei L; Wang W
J Glob Antimicrob Resist; 2022 Dec; 31():328-336. PubMed ID: 36210030
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, associated factors, outcomes and transmission of extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in São Paulo, Brazil: a cross-sectional study.
Gallo JF; Pinhata JMW; Simonsen V; Galesi VMN; Ferrazoli L; Oliveira RS
Clin Microbiol Infect; 2018 Aug; 24(8):889-895. PubMed ID: 29175351
[TBL] [Abstract][Full Text] [Related]
8. Multidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, China.
Qi YC; Ma MJ; Li DJ; Chen MJ; Lu QB; Li XJ; Li JL; Liu W; Cao WC
PLoS One; 2012; 7(2):e32103. PubMed ID: 22384153
[TBL] [Abstract][Full Text] [Related]
9. Extensively drug-resistant tuberculosis in california, 1993-2006.
Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of multidrug-resistant tuberculosis in Latin America and the Caribbean: a systematic review and meta-analysis.
Tengan FM; Figueiredo GM; Leite OH; Nunes AK; Manchiero C; Dantas BP; Magri MC; Barone AA; Bernardo WM
Trop Med Int Health; 2020 Sep; 25(9):1065-1078. PubMed ID: 32506718
[TBL] [Abstract][Full Text] [Related]
12. The burden of pre-extensively and extensively drug-resistant tuberculosis among MDR-TB patients in the Amhara region, Ethiopia.
Shibabaw A; Gelaw B; Gebreyes W; Robinson R; Wang SH; Tessema B
PLoS One; 2020; 15(2):e0229040. PubMed ID: 32053661
[TBL] [Abstract][Full Text] [Related]
13. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
[TBL] [Abstract][Full Text] [Related]
14. The differences in drug resistance between drug-resistant tuberculosis patients with and without diabetes mellitus in northeast China: a retrospective study.
Pan Y; Yu Y; Yi Y; Dou X; Lu J; Zhou L
BMC Infect Dis; 2023 Mar; 23(1):162. PubMed ID: 36922787
[TBL] [Abstract][Full Text] [Related]
15. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
16. Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
Ei PW; Aung WW; Nyunt WW; Swe TL; Htwe MM; Win SM; Aung ST; Chang CL; Lee HY; Lee JS
Int J Tuberc Lung Dis; 2018 Jan; 22(1):47-53. PubMed ID: 29297425
[TBL] [Abstract][Full Text] [Related]
17. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
18. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007.
Marks SM; Flood J; Seaworth B; Hirsch-Moverman Y; Armstrong L; Mase S; Salcedo K; Oh P; Graviss EA; Colson PW; Armitige L; Revuelta M; Sheeran K;
Emerg Infect Dis; 2014 May; 20(5):812-21. PubMed ID: 24751166
[TBL] [Abstract][Full Text] [Related]
19. Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.
Sy KTL; Leavitt SV; de Vos M; Dolby T; Bor J; Horsburgh CR; Warren RM; Streicher EM; Jenkins HE; Jacobson KR
Sci Rep; 2022 Jun; 12(1):10844. PubMed ID: 35760977
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
